Closing the education gap in DoxyPEP implementation and STI-related non-prescription antibiotic use
Abstract
Background: Risk-based STI prevention requires people to recognise exposure, understand indications, and seek testing and counselling. As DoxyPEP becomes more visible, emerging evidence indicates both inappropriate patterns of doxycycline use, including non-recommended regimens or use outside clinical guidance, and broader STI-related antibiotic self-medication. This creates an education gap: people may confuse structured prophylaxis with informal antibiotic use, potentially delaying diagnosis, reducing counselling opportunities and challenging antimicrobial stewardship.
Objectives: To develop a transferable education and outreach framework supporting safer DoxyPEP implementation and reducing STI-related non-prescription antibiotic use across clinical, community, pharmacy and digital settings.
Results: The framework includes five priorities: clear messages on when DoxyPEP is appropriate and why antibiotics are not interchangeable; co-designed education with LGBTQIA+ organisations to increase trust and reduce stigma; digital and dating-app outreach to reach people outside sexual health services; inclusion of behavioural indicators on informal antibiotic use in research and surveillance; and pharmacy-based referral to STI testing and counselling when antibiotics are requested for possible STI exposure. Community data informing the framework suggest that DoxyPEP experience may involve about one fifth of respondents in some samples, while STI-related antibiotic self-medication may affect about one in ten, supporting the need for targeted education beyond clinic-based pathways.
Conclusions: Safe DoxyPEP implementation depends on health literacy, counselling and linkage to care, not only medication access. Addressing the grey zone between prevention and misuse through community, digital and pharmacy education may strengthen STI prevention, reduce hidden antibiotic misuse and support antimicrobial stewardship.
Key messages: • Safe DoxyPEP implementation requires education that clearly separates evidence-based prophylaxis from unsupervised antibiotic self-medication.
• Community, digital, and pharmacy-based outreach can reach people who remain outside STI services and reduce invisible antibiotic misuse.
Related
- Closing the Education Gap in Anesthesia and Intensive Care Medicine in Somalia: A Proposed Competency-Based Framework for Training and Assessment
- Closing the hepatitis equity gap for migrants: implementation lessons from three European countries
- Long-term abortion and birth rates for 14- to 25-year-olds before and after the implementation of prescription-free emergency contraceptives in Finland
- Knowledge and misconceptions about antibiotic use and antibiotic resistance among secondary school students in Riyadh, Saudi Arabia: implications for school- based antibiotic resistance education
- Effectiveness of Discrete Strategies and Implementation Bundles for Improving Clinician Prescription of Clinical Practice Guideline–Recommended Medications for Atherosclerotic Occlusive Disease: A Systematic Review and Meta‐Analysis
BibTeX
@article{rozza2026closing,
title = {{Closing the education gap in DoxyPEP implementation and STI-related non-prescription antibiotic use}},
author = {D Rozza and I C Antonazzo and L Losa and L G Mantovani and P Ferrara},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.1661},
url = {https://doi.org/10.1093/eurpub/ckag169.1661},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Closing the education gap in DoxyPEP implementation and STI-related non-prescription antibiotic use
AU - D Rozza
AU - I C Antonazzo
AU - L Losa
AU - L G Mantovani
AU - P Ferrara
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.1661
UR - https://doi.org/10.1093/eurpub/ckag169.1661
AB - Background: Risk-based STI prevention requires people to recognise exposure, understand indications, and seek testing and counselling. As DoxyPEP becomes more visible, emerging evidence indicates both inappropriate patterns of doxycycline use, including non-recommended regimens or use outside clinical guidance, and broader STI-related antibiotic self-medication. This creates an education gap: people may confuse structured prophylaxis with informal antibiotic use, potentially delaying diagnosis, reducing counselling opportunities and challenging antimicrobial stewardship. Objectives: To develop a transferable education and outreach framework supporting safer DoxyPEP implementation and reducing STI-related non-prescription antibiotic use across clinical, community, pharmacy and digital settings. Results: The framework includes five priorities: clear messages on when DoxyPEP is appropriate and why antibiotics are not interchangeable; co-designed education with LGBTQIA+ organisations to increase trust and reduce stigma; digital and dating-app outreach to reach people outside sexual health services; inclusion of behavioural indicators on informal antibiotic use in research and surveillance; and pharmacy-based referral to STI testing and counselling when antibiotics are requested for possible STI exposure. Community data informing the framework suggest that DoxyPEP experience may involve about one fifth of respondents in some samples, while STI-related antibiotic self-medication may affect about one in ten, supporting the need for targeted education beyond clinic-based pathways. Conclusions: Safe DoxyPEP implementation depends on health literacy, counselling and linkage to care, not only medication access. Addressing the grey zone between prevention and misuse through community, digital and pharmacy education may strengthen STI prevention, reduce hidden antibiotic misuse and support antimicrobial stewardship. Key messages: • Safe DoxyPEP implementation requires education that clearly separates evidence-based prophylaxis from unsupervised antibiotic self-medication. • Community, digital, and pharmacy-based outreach can reach people who remain outside STI services and reduce invisible antibiotic misuse.
SN - 1101-1262
SN - 1464-360X
ER -